Teva

Teva among generic drugmakers hoping to settle US antitrust probe

We will continue to defend ourselves vigorously in these matters," said Kelley Dougherty, a Teva spokesperson. ... Following the news that Teva is in talks with the DoJ, its shares were up 6.5%.

Teva names new CFO and bulks up its opioid liability fund

Under that settlement, Teva would pay $250m in cash over ten years and donate $23bn-worth of drugs to treat opioid addiction, without admitting any wrongdoing. ... rheumatoid arthritis, Teva and Celltrion’s drug is expected to make quick headway in the

Sandoz finally wins FDA approval for Neulasta biosimilar

This includes all biosimilars, biopharmaceutical contract manufacturing and Glatopa sales – Sandoz’ generic of Teva’s multiple sclerosis drug Copaxone.

UPDATED: Ohio opioid trial averted by last-minute settlement

Teva is also due to pay $45m in cash and addiction treatments. ... Teva is in the midst of a challenging time financially at the moment so is trying to avoid a cash settlement, opting instead to provide $15bn worth of drugs and some

J&J proposes $4bn in cash to settle opioid crisis allegations

In addition, Teva Pharmaceuticals has offered medications up to a value of $15bn as part of a proposed deal, and has offered to provide distribution services.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]